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Today’s fast moving lifestyle and modernization has 
caused change in food pattern of human beings, and 
they have little time to think what they are eating is a 
healthy diet. Globalization has seriously affected one’s 
eating habits  and enforced  many  people to consume  
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fancy and high calorie fast foods, popularly known as 
Junk foods. A set of fairly satisfactory dietic codes had 
been identified and prescribed by Ayurveda.  
Any modifications in diets and even in their 
preparation style leads to ill health. Ayurveda explains 
the concept of Nitya Sevaniya (consumable) and 
Atisevaniya Varjya Dravyas (non conumable). 
Trividha Atisevana Varjya Dravyas has been explained 
by Acharya Charaka in Rasavimaniya Adhyaya of 
Vimanasthana.  
Pippali (Piper longum), Kshara (Alkali) and Lavana 
(salt) should not be consumed in excess quantity. If 
consumed it will cause various hazards. Among these 
three Dravyas, Lavana has been selected for the 
present study.  
A B S T R A C T  
Background: Lavana is used as medicine as well as Ahara since ancient times. In Caraka Samhita it 
has been mentioned that three Dravyas viz. Pippali, Kshara (alkali) and Lavana (salt) can be used as 
emergency medicine, but they should not be consumed in excess (Ati Upayunjita). Hence in the 
present study Lavana has been evaluated in experimental animals in two different phases’ viz. Acute 
administration at graded doses as part of acute toxicity study and Sub-Acute administration at fixed 
dose level, as part of toxic Sub-Acute toxicity study, to assess the possible adverse effects. Materials 
& Methods: Wistar strain albino rats of either sex weighing between 150 - 200g. body weights were 
used, The experiment was carried out in accordance with the direction of the Institutional animal 
ethics committee (IAEC) after obtaining its permission (Approval number IAEC – 138/k/2018). 
Results: Results were drawn based on histopathological reports and biochemical reports of each 
group of toxicity study. Acute toxicity study has been carried out in albino rats receiving the 2 dose 
level maximum at up to 10 times higher (855mg/kg) then the therapeutic equivalent dose 
(427.5mg/kg).  In Sub-Chronic toxicity: dose given was five times higher than therapeutic equivalent 
dose and ten times the equivalent to human therapeutic dose for duration of 30 days. Discussion: 
Toxicity is not found in Acute study and in Sub-Acute study moderate to high toxicity is found. 
Key words: Acute, Sub-acute, Toxicity, Lavana, Salt. 
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OBJECTIVE OF THE STUDY 
1. To collect, compile and experimentally analyze 
the concept of ‘Trividha Ati Sevaniya Varjya 
Dravya’s w.s.r. to Lavana. 
2. To evaluate the effect of Lavana (Samudra 
Lavana) - experimentally in context of Ati Sevana 
Varjya. 
3. To evaluate the sub-acute toxic effect of Lavana 
(Samudra Lavana) in albino rat two different dose 
levels. 
MATERIALS AND METHODS 
Materials 
Test Drug 
The test drug i.e. Lavana (sodium chloride) for the 
present study was procured from the Pharmacy of 
Rasashastra and Bhaishajya Kalpana, BLDEA’S AVS 
Ayurveda Mahavidyalaya, Vijayapur. 
Experimental animals 
▪ Wister strain albino rats were selected from Sri 
Venkateshwara Enterprises, suppliers of 
Laboratory animals, Bangalore. (CPCSEA =237). 
▪ The rats were maintained under strict laboratory 
conditions, controlled with environmental 
temperature, humidity and light dark cycles. 
▪ The rats were fed with balanced pellet diet as 
prescribed by CFTRI and water and libitum. 
Inclusive criteria 
▪ Healthy albino rats of either sex will be 
considered. 
▪ Weighing about 150-200g 
▪ Albino rats between 90 -120 days were included. 
Exclusion criteria 
▪ Rats less than 150g and more than 200g. 
▪ Pregnant and diseased rats. 
▪ Rats which are under trial of other experiments. 
Mode of Administration 
Drugs were administered through Oral route. 16 no. 
needle bent slightly at its tip and inserted into a cut IV 
tube to the length of needle to prevent oral injury. 
Needle fixed to the 2 ml syringe. 
Plan of the Study 
The study is planned in two different phases as 
follows, 
▪ Acute toxicity study - 9 Albino rats 
▪ Sub -acute toxicity study - 12 Albino rats 
Method 
The Toxicological studies will be conducted according 
to Ayush Guidelines for screening for toxicity in the 
Animal house attached to Dept. of Rasashastra and 
Bhaishajya. BLDEA’S AVS Vijayapur. Standard 
pharmacological protocol will be adopted for the 
experimental study which will be mentioned in the 
description of experimental study. Whole work is 
planned to generate data from laboratory i.e., 
experiments on animals are performed as described in 
references.  
Rat dose was calculated on the basis of Human dose 
by using Standard Conversion Method on the basis of 
body surface area ratio using the table of Paget and 
Barnes. 
Dose calculation 
Recommended human dose of  Lavana (Common Salt) 
-  5gms/day 
 Rat dose = Human dose x 0.018 (for 200gm of body 
weight)                                    
 = 5 x 0.018 
 = 0.09gm 
 = 90mg 
Acute study 
▪ Study was divided in to 3 groups. Each group 
contain 3 rats. 
▪ Recommended test dose is given to all the 
groups. 
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▪ Observed for 24 hrs, and after 24 hrs. Then 
scarifies was done. Blood is collected for 
laboratory investigation and organs sent for 
Histopathology. 
No of Rats Control 
Group 
TED X 5 TED X 10 
Rat 1 Water 382.5 mg 765 mg 
Rat 2 Water 427.5 mg 855 mg 
Rat 3 Water 427.5 mg 855 mg 
Sub-acute Study 
1. Study is divided in to 4 groups. Each group contain 
3 rats. 
2. Recommended dose is given to all the groups. 
3. For 30 days dose is given. On 31st  day scarifies is 
done. 
No of Rats Control 
Group 
TED  TED X 5 TED X 10 
Rat 1 Water 67.5 mg 382.5 mg 720 mg 
Rat 2 Water 67.5 mg 427 mg 697.5 mg 
Rat 3 Water 67.5 mg 427 mg 697 mg 
TED - Therapeutic Equivalent Dose. 
Statistical analysis 
The data generated is mentioned as Mean ± SEM. 
Difference among the groups is assessed by 
employing one way ANOVA with Dunnet’s multiple‘t’ 
test. 
If P value is less than 0.05 - There is a significant 
difference. 
If P value is more than 0.05 - There is no significant 
difference. 
OBSERVATIONS AND RESULTS 
Acute Group 
No major difference has been observed in acute 
groups after giving respective doses. Even up to 
855mg/kg dose level no mortality and behavioural 
changes were observed. 
Sub Acute Group 
▪ 3 rats in a group 4 TED X 10, 3 rats died during 
the experiment. 1st expired on 5th  day during the 
experiment 2nd rat on 8th day, and 3rd rat on 9th 
day during experiment. 
▪ The rats belonging to TED X 5 group, were 
looking unhealthy at the end of the experiment. 
Acute Study 
Effect on Haematological and Biochemical 
Parameters. 
SN Parameter Control 
Group 
TED X 5 TED X 10 
1. Total WBC count  NSD NSD NSD 
2. Diff. count NSD NSD NSD 
3. Lymphocytes % NSD NSD NSD 
4. Eosinophils % NSD NSD NSD 
5. Monocytes % NSD NSD NSD 
6. Basophils % SD  SD SD 
7. RBC count NSD NSD NSD 
8. Haemoglobin % NSD NSD NSD 
9. Heamacrite NSD NSD NSD 
10. MCV NSD NSD NSD 
11. MCH NSD NSD NSD 
12. MCHC NSD NSD NSD 
13. RDW NSD NSD NSD 
14. Platelet count SD SD SD 
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15. Platelet volume NSD NSD NSD 
16. PCT NSD NSD NSD 
17. Platelet distribution 
width 
NSD NSD NSD 
18. SGOT NSD NSD NSD 
19. SGPT SD SD SD 
20. Blood urea SD SD SD 
21. Alkaline phosphate NSD NSD NSD 
22. S. creatinine SD  SD SD 
NSD : Non Significant Difference, SD : Significant Difference 
Table 4: Summary of the data on Histopathological 
changes of the organs recorded during acute toxicity 
study. 
SN Organs Control Group TED X 5 TED X 10 
1. Brain Rat 1 - NSC 
Rat 2 - NSC 
Rat 3 - NSC 
Rat 1 - SC 
Rat 2 - NSC 
Rat 3 - SC 
Rat 1 - NSC 
Rat 2 -  SC 
Rat 3 - SC 
2. Left 
kidney 
Rat 1 - NSC 
Rat 2 - NSC 
Rat 3 - NSC 
Rat 1 - NSC 
Rat 2 - NSC 
Rat 3 - NSC 
Rat 1 - NSC 
Rat 2 - NSC 
Rat 3 - NSC 
3. Right 
kidney 
Rat 1 - NSC 
Rat 2 - NSC 
Rat 3 - NSC 
Rat 1 - NSC 
Rat 2 - NSC 
Rat 3 - NSC 
Rat 1 - NSC 
Rat 2 - NSC 
Rat 3 - NSC 
4. Left 
lung 
Rat 1 - NSC 
Rat 2 - NSC 
Rat 3 - NSC 
Rat 1 - SC 
Rat 2 - SC 
Rat 3 - SC 
Rat 1 -NSC 
Rat 2 -SC 
Rat 3 - SC 
5. Right 
lung 
Rat 1 - NSC 
Rat 2 - NSC 
Rat 3 - NSC 
Rat 1 - SC 
Rat 2 - SC 
Rat 3 - SC 
Rat 1 - NSC 
Rat 2 - SC 
Rat 3 - SC 
6. Liver Rat 1 - NSC Rat 1 - NSC Rat 1 - NSC 
 Rat 2 - NSC 
Rat 3 - NSC 
Rat 2 - SC 
Rat 3 - SC 
Rat 2 - NSC 
Rat 3 - SC 
7. Spleen 
 
Rat 1 - NSC 
Rat 2 - NSC 
Rat 3 - NSC 
Rat 1 - SC 
Rat 2 - NSC 
Rat 3 - NSC 
Rat 1 - NSC 
Rat 2 - NSC 
Rat 3 - NSC 
8. Heart 
 
Rat 1 - NSC 
Rat 2 - NSC 
Rat 3 - NSC 
Rat 1 - SC 
Rat 2 - NSC 
Rat 3 - SC 
Rat 1 - NSC 
Rat 2 - NSC 
Rat 3 - SC 
NSC - No Significant Changes, SC - Significant Change. 
Sub-acute Study 
Effect on Haematological and Biochemical 
Parameters 
SN  Parameter Control 
Group 
TED TED X 5 
1. Total WBC count  NSD NSD NSD 
2. Diff. count NSD NSD NSD 
3. Lymphocytes % NSD NSD NSD 
4. Eosinophils % NSD NSD NSD 
5. Monocytes % NSD NSD NSD 
6. Basophils % NSD NSD NSD 
7. RBC count NSD NSD NSD 
8. Haemoglobin % NSD NSD NSD 
9. Heamacrite NSD NSD NSD 
10. MCV NSD NSD NSD 
11. MCH NSD NSD NSD 
12. MCHC NSD NSD NSD 
13. RDW NSD NSD NSD 
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14. Platelet count NSD NSD NSD 
15. Platelet volume NSD NSD NSD 
16. PCT NSD NSD NSD 
17. Platelet 
distribution width 
NSD NSD NSD 
18. SGOT NSD NSD NSD 
19. SGPT NSD NSD NSD 
20. Blood urea NSD NSD NSD 
21. Alkaline 
phosphate 
SD SD SD 
22. S. creatinine SD  SD SD 
Summary of the data on Histopathological changes 
of the organs recorded during sub-acute toxicity 
study. 
SN Organs Control 
Group 
TED TED X 5 TED X 10 
1. Brain Rat 1 - 
NSC 
Rat 2 - 
NSC 
Rat 3 - 
NSC 
Rat 1 - NSC 
Rat 2 - NSC 
Rat 3 - NSC 
Rat 1 - 
NSC 
Rat 2 - 
NSC 
Rat 3 - SC 






Rat 1 - 
NSC 
Rat 2 - 
NSC 
Rat 3 - 
NSC 
Rat 1 - NSC 
Rat 2 - NSC 
Rat 3 - NSC 
Rat 1 - 
NSC 
Rat 2 - 
NSC 
Rat 3 - 
NSC 





Rat 1 - 
NSC 
Rat 2 - 
NSC 
Rat 3 - 
NSC 
Rat 1 - NSC 
Rat 2 - NSC 
Rat 3 -SC 
Rat 1 - 
NSC 
Rat 2 - 
NSC 
Rat 3 - 
NSC 
Rat 1 - 
SC 
 
4. Left Rat 1 - Rat 1 - SC Rat 1 - SC Rat 1 - 
lung NSC 
Rat 2 - 
NSC 
Rat 3 - 
NSC 
Rat 2 - SC 
Rat 3 - SC 
Rat 2 - SC 





Rat 1 - 
NSC 
Rat 2 - 
NSC 
Rat 3 - 
NSC 
Rat 1 - SC 
Rat 2 - SC 
Rat 3 - SC 
Rat 1 - SC 
Rat 2 - SC 
Rat 3 - SC 





Rat 1 - 
NSC 
Rat 2 - 
NSC 
Rat 3 - 
NSC 
Rat 1 - SC 
Rat 2 - NSC 
Rat 3 - SC 
Rat 1 - 
NSC 
Rat 2 - 
NSC 
Rat 3 - 
NSC 





Rat 1 - 
NSC 
Rat 2 - 
NSC 
Rat 3 - 
NSC 
Rat 1 - NSC 
Rat 2 - NSC 
Rat 3 - NSC 
Rat 1 - 
NSC 
Rat 2 - 
NSC 






Rat 1 - 
NSC 
Rat 2 - 
NSC 
Rat 3 - 
NSC 
Rat 1 - SC 
Rat 2 - NSC 
Rat 3 - SC 
Rat 1 - 
NSC 
Rat 2 - 
NSC 
Rat 3 - 
NSC 




In the present study Lavana is taken, there are five 
types of Lavana, in which Samudra Lavana is used for 
present study, among the types of  Lavana’s, 
Saindhava Lavana is said to best for internal use.   
Acute Study 
There are totally 22 parameters referred in blood 
investigation report. Statistically we see significant 
difference in Basophils and mild increase in TED X 5 
group in Rat 2, may be due to chronic non-specific 
inflammation in some organs. Statistically there is no 
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significant difference in all RBC related parameters. All 
are normal. Statistically there is significant difference, 
we find mild increase in platelet count in TED X 5, TED 
X 10 group Rats due to chronic nonspecific 
inflammation in some organs. Statistically we see that 
there is a significant difference in SGPT, Blood urea, S. 
Creatinine and moderately increase in SGOT levels in 
TED X 5 and TED X 10 groups in all rats, increase in 
SGPT in TED X 10 group rats, and increase in Alkaline 
phosphate in TED X 5, TED X 10 group rats, these all 
may be due to Chronic Nonspecific Inflammation. 
Over all there is a mild to moderate increase in some 
parameters in blood. 
In the present study, in acute there are 3 groups, In 
Group 1 (control group) histopathology level all the 
organs are normal, in this group experimental drug 
was not given to rats only water was given to rats. 
Histopathology report of group 3 (TED X 5) and group 
4 (TED X 10). In present Acute study, in group 2 (TED X 
5) Rats, histopathologically we found that in both the 
lungs of all 3 Rats there was a congested blood vessels 
and diffuse lymphocytic infiltration to interstium and 
occasional lymphoid aggregates were noted, due to 
this there is a mild increase in Basophill count and 
mild increase in platelet count in all three Rats. There 
is a mild increase in SGOT and SGPT and alkaline 
phosphate in Rat 2 and Rat 3, this may be due to 
congested blood vessels and mononuclear cell 
infiltration the portal triad also noted fatty changes at 
the places in liver. All these suggest that least amount 
of toxicity was found in acute study of group 2. In 
Group 3 (TED X 10) , in Rat 2 and Rat 3, we found 
congested blood vessels and occasional perivascular 
lymphocytic infiltration in brain and focal area of 
haemorrhage, this may also occur in process of death. 
And in Rat 3 in liver, histopathologically we found 
congested blood vessels and mono nuclear cell 
infiltration portal triad and also noted fatty changes at 
places due to this there is a moderate increase in 
SGOT, SGPT and alkaline phosphate. There is a mild 
change in platelet count may be due to congested 
blood vessels and diffuse lymphocytic infiltration in to 
interstium, occasional lymphoid aggregates seen in 
right and left lung in Rat 2 and Rat 3. All these suggest 
that there might be a mild toxic level in acute group 3 
at dose level of TED X 10. 
Sub Acute Study 
Statistically there is no significant in all rats. In group 2 
there is mild increase in WBC count in rat 3, and in 
group 3,mild increase in WBC count in rat 1,2,3 and 
mild increase in lymphocytes in all rats of group 2 and 
group 3. May be due to chronic nonspecific 
inflammation in some organs. Other parameters are 
normal. Statistically there is no significant difference 
in all RBC related parameters. May be due to chronic 
non-specific inflammation in some organs. Other 
parameters are normal. Statistically there is no 
significant in all rats. But mild increase in platelet 
count in group 2 and group 3 in rat 2 &3. May be due 
to chronic non-specific inflammation in some organs. 
Other parameters are normal. There is statistically 
significant difference in Alkaline phosphate and S. 
Creatinine in all groups. In group 2 there is mild 
increase SGOT,SGPT, moderate increase in alkaline 
phosphate in rat 3 this may be due to chronic 
nonspecific inflammation where as in group 3 mild 
increase in alkaline phosphate in rat 1, rat 2 , highly 
increase in SGOT, SGPT in rat 1 and in rat 3 may be 
due to chronic non-specific inflammation. 
In Histopathalogy study, in sub-acute group 2 (TED), 
histopathalogy in both lungs of Rat 1 and Rat 2 found 
congested blood vessels were seen diffused 
lymphocytic infiltration in to interstium and a place of 
lymphoid aggregates were seen, this causes mild 
variation in WBC count and mild increase in platelet 
count. Left lung is normal in Rat 3 where as in right 
lung congested blood vessels and focal area of 
haemorrhage was seen. Mild increase in SGOT, SGPT, 
moderate increase in alkaline phosphate was seen, 
this may be due to congested blood vessels and focal 
area of haemorrhage in Rat 3 in right kidney. This 
suggests that there may be mild toxic effect in all Rats. 
In Group 3 - in Rat 3, there is a mild increase in WBC 
count and platelet count which may be due to 
congested blood vessels and focal areas of 
haemorrhage and mono nuclear cell Infiltration in 
right and left lung in Rat 2 & 3, there is a congested 
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blood vessels were also seen, diffused lymphocytic 
infiltration in to interstium at places, lymphoid 
aggregates were seen, this causes highly increase in 
SGOT & mild increase of Alkaline phosphate in Rat 1 & 
3. All these suggest that moderate toxicity can be 
found in group 3 (TED X 5). As discussed earlier all 
Rats died in between the experiment, only one Rat 
organs were able to send for histopathology study. 
Report says that there is a congested blood vessels 
and lymphocytic infiltration in portal triad. At this 
dose level TED X 10 toxicity is found. All these 
suggests that Highly toxicity can be seen in group 4 
(TED X 10). 
Microphotographs Acute toxicity Study (Ted X 10) 
 








Based on present study, Lavana is again proved to be 
Atisevaniya Varjya Dravya. So we should not consume 
excess to avoid health hazards. By animal experiment, 
we found in acute group no toxicity was found, where 
as in Sub-acute group moderate to high toxicity was 
found. Thus Lavana should not be consumed in 
excess. 
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